Clinical Trial Update: Evaluation of Myocardial Effects of MTP-131 for Reducing Reperfusion Injury in Patients With Acute Coronary Events [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the myocardial effects of MTP-131 to reduce reperfusion injury in patients with acute coronary events has completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Reperfusion Injury
• Stemi

Drugs mentioned

• MTP-131 (elamipretide)

Snippet

Sponsor: Stealth BioTherapeutics Inc. | Conditions: Reperfusion Injury, STEMI | Phase 2 | Status: COMPLETED | Results posted: 2020-06-11